Members only

Finance Featured

Who Owns Your Doctor?

More than 80% of American physicians now work for a hospital, insurer, or investor-owned group. A new federal bill would force the buyers out — here is the ticker-by-ticker exposure map.

Paid-members only

Investing Featured

The Transcontinental Railroad Is Trading at 87 Cents on the Dollar

Union Pacific's $85 billion bid for Norfolk Southern faces its decisive window: all opposition lands at the STB by November 18, BNSF has declared war, and the arb spread says the market has real doubts. Here's the scenario math.

Paid-members only

Markets Featured

$INOD: 550 Jobs Cut Mid-Shift, a 25% Crash, and Earnings in Eight Days. The Filings Tell a Different Story

Innodata cut ~550 workers mid-shift with no press release and the stock lost a quarter of its value on fears it lost its biggest AI customer. The concentration math, the real cash net of customer prepayments, the $300M ATM, and scenario zones into the November 5 print.

Macro Featured

The Fed's $2.5 Trillion Cushion Is Down to $226 Million

The Fed decides on rates today, but the real story is in the plumbing: the overnight buffer that absorbed four years of Treasury borrowing is gone, bank reserves are falling, and overnight money is trading above the Fed's floor.

Markets Featured

The Vibecession Goes Holiday Shopping

Consumer sentiment just printed lower than any reading before 2026 — below the 1980 oil shock and the 2008 crash — while forecasters call for the strongest holiday spending since 2022. Both numbers are telling the truth.

Paid-members only

Space Economy Featured

SpaceX Declared War on the Carriers. AST SpaceMobile Is the Collateral Damage.

SpaceX's $8 billion spectrum grab sent AST SpaceMobile to a 52-week low — weeks before it switches on nationwide satellite-to-phone coverage. The bear math, the bull case, and the dated catalysts that decide which one wins.

Members only

Defence Featured

The Missile Shield With No Budget Line

Golden Dome has obligated 90% of the only appropriation Congress ever gave it, the stopgap now funding the government gives it zero, and the decision lands December 11. Here's who's exposed.

Members only

Geopolitics Featured

The Students Won Serbia. The First Deadline Is Friday.

A student-led movement just ended 14 years of one-party rule in Belgrade — and inherited a sanctioned Russian-owned oil company whose US waiver runs out Friday, Europe's most contested lithium project, and a stack of state megacontracts it has promised to reopen.

Infrastructure Featured

San Francisco Tried to Buy Its Grid. PG&E Sent Back a $22.5 Billion Invoice.

PG&E says San Francisco would owe $22.5 billion to take over its own grid — more than six times the city's estimate. The gap is really an exit fee, and the ruling on it will decide whether any American city can afford to leave its utility.

Members only

Markets Featured

A Bug in 70% of the Web Just Repriced the Entire Cybersecurity Sector

Two PHP flaws put most of the web on emergency patch duty — and while the S&P fell, the market added 10-24% to nearly every cybersecurity name in four sessions. Inside the repricing, and whether it holds.

Infrastructure Featured

Your Electric Bill Is on the Ballot

Capacity prices in America's largest power market are up more than tenfold in three auctions, data centers are the reason, and one week before the midterms both parties are running against them. The grid is now a ballot issue.

Paid-members only

Markets Featured

The Benchmark That Prices Oil at Sea Is on Trial

October was the worst month ever recorded for tanker attacks in the Strait of Hormuz — and a London court is now deciding whether eight months of the world's benchmark supertanker rate were invalid. What it means for the tanker trade, and the two November dates that matter.

Members only

Finance Featured

Wall Street Is Buying Phase 1 Again

A food-allergy biotech with one cohort of human data just closed a $365 million IPO and trades near a $1.5 billion valuation. Biotech's IPO class of 2026 says the window is wide open. The aftermarket scoreboard says mind which side of it you're standing on.

Markets Featured

$CLS: Celestica Guides to 90% Growth in 2027 and the Market Is Paying 13x for It. Here's the Catch

Celestica beat Q3 on every line, revenue up 83%, and guided 2027 to $40 billion. The stock popped 11% premarket yet trades at 12.7x the new guide. The three-customer concentration math, the free cash flow cut, the $310 equity raise signal, and the scenario zones.

Markets Featured

$PBR: The Market Priced In a Bolsonaro Win. Lula's Fourth Term Erased $34 Billion Before the Open

Petrobras ADRs are down 21% premarket after Lula's shock runoff win. The dividend formula, the fuel-price gap at $110 Brent, the November 10 date, and the scenario zones.

Paid-members only

Markets Featured

Top 10 Stocks We're Watching This Week — Decision Week Edition

A Fed hold Wednesday with Microsoft hours later, Brent at six-month highs on the worst Hormuz month of the war, and eight of our ten reporting earnings this week. Ten names for decision week, all tracked on the Watchlist from these prices.

Members only

Finance Featured

Private Credit Isn't Defaulting. It's Deferring.

Moody's counts a 4% default rate in US private credit — until it counts the borrowers paying interest with more debt. Then it's 5.8%. Inside the deferral economy, and what the BDC tape is pricing next.

Members only

Energy Featured

Why Is America Importing Russian Diesel?

A Russian tanker is steaming toward a US port, Washington is lending out a third of its emergency heating oil reserve, and retail diesel is above $6 a gallon. The crisis isn't crude — it's refining. Here's what that distinction is worth.

Geopolitics Featured

Washington Just Moved to Wall Off Chinese Biotech. Big Pharma Got a Door.

Treasury's proposed COINS Act rules would bar U.S. equity investment across broad swaths of Chinese biotech -- while sparing pharma's record-setting cash licensing deals. What's banned, what's exempt, and what it means for the industry.

Paid-members only

Markets Featured

$MRNA: Up 6x This Year, Down 18% on Good News. What the Leaked Cancer Vaccine Data Actually Says

Moderna fell 17.6% after its Phase 3 melanoma vaccine data leaked early: a 42% recurrence-risk reduction against a 49% anchor the market had priced for. The trial-design detail the sellers skipped, the 50/50 Merck math, and the scenario zones into Saturday's ESMO presentation.

Members only

Markets Featured

Nobody Canceled Netflix. They Just Stopped Watching.

Netflix beat earnings, grew revenue 12%, and bought back a record $4.8 billion of stock — then fell to a two-year low. The market isn't pricing the quarter. It's pricing the hours.

Paid-members only

Markets Featured

The Private Key Was the Number 4

Eight secret keys guarding the web were small enough to guess by hand — one was 4. Five days later, eMudhra has lost a third of its market value and its global TLS business. The company calls it 1% of revenue. The market is pricing something much bigger.

Macro Featured

The Layoffs Are at Four-Year Lows. AI Just Became the Top Reason for Them.

U.S. layoffs are at a four-year low, hiring is the weakest since 2011 — and AI just became the most-cited reason American employers give for cutting jobs. Barclays' 5,000-job cut shows how the new workforce math works.

Paid-members only

Markets Featured

$CRWV: The Bonds Yield 15%, Goldman Says Buy. Inside CoreWeave's $35 Billion Debt Stack

CoreWeave's stock is down 56% while its order book hit $104 billion. The bond market just repriced the company's debt to distress levels and Goldman upgraded into it. The numbers on both sides of that argument, itemized.

Paid-members only

Geopolitics Featured

Who Gets Paid When Venezuela Reopens?

Maduro is awaiting trial in New York, Washington owns 35% of a Barbados-registered oil venture, and more than $100 billion in defaulted claims is lining up behind every new barrel. The queue — not the oil — is the trade.